Adona Interatrial Shunt System
Heart Failure (for reduction of left atrial pressure)
First-in-HumanActive
Key Facts
Indication
Heart Failure (for reduction of left atrial pressure)
Phase
First-in-Human
Status
Active
Company
About Adona Medical
Adona Medical is pioneering a next-generation, minimally invasive solution for heart failure with its investigational Adona Interatrial Shunt system. The device's key differentiators are its post-implant adjustability, enabled by shape-memory nitinol and a proprietary induction catheter, and its integrated bi-atrial pressure monitoring sensors. The company has raised significant venture capital, completed enrollment in its first-in-human trial as of mid-2025, and is positioned to address a significant unmet need in the structural heart and advanced heart failure markets.
View full company profile